Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

RIBOSOMAL P EIA TEST SYSTEM

K-Number: K950169 · 1996-05-23

ApplicantHogan & Hartson
Decision Date1996-05-23
Product CodeMQA
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

RIBOSOMAL P EIA TEST SYSTEM is the device name listed in this FDA 510(k) record. The listed applicant is Hogan & Hartson. It received FDA 510(k) clearance on 1996-05-23 under 510(k) number K950169. The device is classified under product code MQA. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the RIBOSOMAL P EIA TEST SYSTEM?

RIBOSOMAL P EIA TEST SYSTEM is a medical device that received FDA 510(k) clearance on 1996-05-23. The listed applicant is Hogan & Hartson. The 510(k) number is K950169.

When did RIBOSOMAL P EIA TEST SYSTEM receive FDA 510(k) clearance?

RIBOSOMAL P EIA TEST SYSTEM received FDA 510(k) clearance on 1996-05-23, under 510(k) number K950169.

Who is the listed applicant for RIBOSOMAL P EIA TEST SYSTEM?

The FDA 510(k) record lists Hogan & Hartson as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for RIBOSOMAL P EIA TEST SYSTEM?

The FDA product code for RIBOSOMAL P EIA TEST SYSTEM is MQA.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Hogan & Hartson as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K974168COOPERSURGICAL INFRARED COAGULATORK973849BIOABSORBABLE BANKART TACKK973162DUAL RADIATION TARGETING SYSTEM DRTS DRAPEK942389TROCARS, TROCAR SLEEVES AND REDUCTION SLEEVESK946216CARDIOLIPIN A EIA TEST SYSTEMK946217CARDIOLIPIN M EIA TEST SYSTEM

View all 26 devices →

Related Devices (Code: MQA)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K202540EliA Rib-PPhadia ABK024151EL-ANA PROFILES: ANTI-RIBOSOMAL PROTEIN PTheratest Laboratories, Inc.K981237QUANTA LITE RIBOSOME P ELISAInova Diagnostics, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑